14.3 C
New York
Tuesday, March 21, 2023

What Are The Chances Of C4 Therapeutics Inc. (NASDAQ: CCCC) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for C4 Therapeutics Inc. (CCCC) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.22, or -5.02%, to $4.16. The C4 Therapeutics Inc. has recorded 19,689 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that C4 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

As a NASDAQ listed company, CCCC falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $4.38 and fluctuated between $4.6700 as its day high and $4.2100 as its day low. The current market capitalization of C4 Therapeutics Inc. is $229.12M. A total of 0.63 million shares were traded on the day, compared to an average of 534.82K shares.

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, CCCC has seen 12 BUY and 7 SELL insider trades, representing the acquisition of 40,768 and the disposition of 12,046 shares. Over the last 12 months, there were 26 BUYs and 14 SELLs from insiders. Insiders purchased 87,560 shares during that period but sold 22,333.

In the most recent transaction, Koppikar Utpal bought 5,667 shares of CCCC for 5.60 per share on Feb 08. After the transaction, the Director now owns 5,667 company shares. In a previous transaction on Apr 12, Hirsch Andrew bought 10,000 shares at 8.40 per share. CCCC shares that President & CEO owns now total 10,000.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for CCCC in the last 3 months, the mean price target is $21.54 with high estimates of $84.00 and low estimates of $5.00. In terms of 52-week highs and lows, CCCC has a high of $26.80 and a low of $4.64.

As of this writing, CCCC has an earnings estimate of -$0.74 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.58 per share and a lower estimate of -$0.9. The company reported an EPS of -$0.56 in the last quarter, which was 18.80% higher than expectations of -$0.69.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 13 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CCCC is Hold with a score of 3.56. A total of 7 analysts rated the stock as Buy while 0 rated it as Overweight while 4 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 2 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles